Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7659)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2017 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tornai T, Palyu E, Vitalis Z, Tornai I, Tornai D, Antal-Szalmas P, Norman GL, Shums Z, Veres G, Dezsofi A, Par G, Par A, Orosz P, Szalay F, Lakatos PL, Papp M. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis. World J Gastroenterol 2017; 23(29): 5412-5421 [PMID: 28839442 DOI: 10.3748/wjg.v23.i29.5412] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i29/5412.htm |
| Number | Citing Articles |
| 1 |
Michael Camilleri. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 2019; 68(8): 1516 doi: 10.1136/gutjnl-2019-318427
|
| 2 |
Daniel M. Chopyk, Arash Grakoui. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. Gastroenterology 2020; 159(3): 849 doi: 10.1053/j.gastro.2020.04.077
|
| 3 |
Trevor J Laborda, M Kyle Jensen, Marianne Kavan, Mark Deneau. Treatment of primary sclerosing cholangitis in children. World Journal of Hepatology 2019; 11(1): 19-36 doi: 10.4254/wjh.v11.i1.19
|
| 4 |
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher. The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective. Cells 2021; 10(11): 2959 doi: 10.3390/cells10112959
|
| 5 |
Ya. A. Krasner, Yu. A. Kulygina, E. Yu. Valuyskikh, M. F. Osipenko. Prevalence and characteristics of non-alcoholic steatohepatitis in patients with inflammatory bowel disease in the Novosibirsk region: a cross-sectional, one center study in 245 patients. Almanac of Clinical Medicine 2018; 46(5): 464 doi: 10.18786/2072-0505-2018-46-5-464-473
|
| 6 |
Andreas Blesl, Vanessa Stadlbauer. The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 2021; 13(3): 1018 doi: 10.3390/nu13031018
|
| 7 |
Mark W Russo. Noninvasive prognostic models, imaging, and elastography to predict clinical events in primary sclerosing cholangitis: A review. World Journal of Hepatology 2023; 15(9): 1013-1020 doi: 10.4254/wjh.v15.i9.1013
Abstract(175) |
Core Tip(158) |
Full Article(HTML)(837)
|
Full Article with Cover (PDF)-1672K(51)
|
Full Article (Word)-368K(25)
|
Audio-369K(3)
|
Peer-Review Report-234K(32)
|
Answering Reviewers-405K(31)
|
Full Article (PDF)-822K(93)
|
Full Article (XML)-122K(24)
|
Times Cited (0)
|
Total Visits (2345)
|
Open
|
| 8 |
Yu‐Chieh Weng, Wei‐Ting Chen, Jung‐Chieh Lee, Yung‐Ning Huang, Chih‐Kai Yang, Hui‐Shan Hsieh, Chih‐Jung Chang, Yang‐Bor Lu. Intestinal fatty acid‐binding protein is a biomarker for diagnosis of biliary tract infection. JGH Open 2021; 5(10): 1160 doi: 10.1002/jgh3.12644
|
| 9 |
Luca Maroni, Elisabetta Ninfole, Claudio Pinto, Antonio Benedetti, Marco Marzioni. Gut–Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology. Cells 2020; 9(3): 736 doi: 10.3390/cells9030736
|
| 10 |
David Tornai, Peter Laszlo Ven, Peter Laszlo Lakatos, Maria Papp. Serological biomarkers for management of primary sclerosing cholangitis. World Journal of Gastroenterology 2022; 28(21): 2291-2301 doi: 10.3748/wjg.v28.i21.2291
|
| 11 |
Ruslan A. Mammadov, Jasmijn W. Selten, Henk P. Roest, Cornelia J. Verhoeven, Luca Maroni, Sandra I. Bril, Dagmar Tolenaars, Pravesh S. Gadjradj, Stan F.J. van de Graaf, Ronald P.J. Oude Elferink, Jaap Kwekkeboom, Herold J. Metselaar, Maikel P. Peppelenbosch, Ulrich Beuers, Jan N.M. IJzermans, Luc J.W. van der Laan. Intestinal Bacteremia After Liver Transplantation Is a Risk Factor for Recurrence of Primary Sclerosing Cholangitis. Transplantation 2023; 107(8): 1764 doi: 10.1097/TP.0000000000004563
|
| 12 |
Jixuan Wang, Zhiwen Sun, Jingri Xie, Wanli Ji, Yang Cui, Zongxiong Ai, Guoying Liang. Inflammasome and pyroptosis in autoimmune liver diseases. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1150879
|
| 13 |
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, Gerald Holtmann. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. American Journal of Gastroenterology 2020; 115(6): 814 doi: 10.14309/ajg.0000000000000604
|
| 14 |
Areej Mazhar, Mark W. Russo. Systematic review: non‐invasive prognostic tests for primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 2021; 53(7): 774 doi: 10.1111/apt.16296
|
| 15 |
Atsushi Oyama, Akinobu Takaki, Takuya Adachi, Nozomu Wada, Yasuto Takeuchi, Hideki Onishi, Hidenori Shiraha, Hiroyuki Okada, Motoyuki Otsuka. Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan. Hepatology International 2023; 17(5): 1215 doi: 10.1007/s12072-023-10557-2
|
| 16 |
Jingyi Shan, Suxian Liu, Haoyue Liu, Jianye Yuan, Jiang Lin. Mechanism of Qingchang Suppository on repairing the intestinal mucosal barrier in ulcerative colitis. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1221849
|
| 17 |
Zhen-Jiao Li, Hong-Zhong Gou, Yu-Lin Zhang, Xiao-Jing Song, Lei Zhang. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World Journal of Gastroenterology 2022; 28(44): 6213-6229 doi: 10.3748/wjg.v28.i44.6213
|
| 18 |
Tamas Dinya, Tamas Tornai, Zsuzsanna Vitalis, Istvan Tornai, Boglárka Balogh, David Tornai, Peter Antal‐Szalmas, Andrea Sumegi, Hajnalka Andrikovics, Andras Bors, Attila Tordai, Maria Papp. Functional polymorphisms of innate immunity receptors are not risk factors for the non‐SBP type bacterial infections in cirrhosis. Liver International 2018; 38(7): 1242 doi: 10.1111/liv.13664
|
| 19 |
Keisaku Sato, Fanyin Meng, Giammarco Fava, Shannon Glaser, Gianfranco Alpini. Functional roles of gut bacteria imbalance in cholangiopathies. Liver Research 2019; 3(1): 40 doi: 10.1016/j.livres.2018.11.001
|
| 20 |
Susana G. Rodrigues, Schalk van der Merwe, Aleksander Krag, Reiner Wiest. Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases. Seminars in Immunology 2024; 71: 101859 doi: 10.1016/j.smim.2023.101859
|
| 21 |
Vandana Jain, Emma C. Alexander, Charlotte Burford, Anita Verma, Anil Dhawan. Gut Microbiome. Journal of Pediatric Gastroenterology and Nutrition 2021; 72(2): 184 doi: 10.1097/MPG.0000000000002973
|
| 22 |
Mauro Giuffrè, Michele Campigotto, Giuseppina Campisciano, Manola Comar, Lory Saveria Crocè. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(5): G889 doi: 10.1152/ajpgi.00161.2019
|
| 23 |
Gary L. Norman, Nicola Bizzaro, Danilo Villalta, Diego Vergani, Giorgina Mieli-Vergani, Gideon M. Hirschfield, Michael Mahler. Precision Medicine and Artificial Intelligence. 2021; : 135 doi: 10.1016/B978-0-12-820239-5.00012-7
|
| 24 |
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi, Johannes R. Hov. Role of microbiome in autoimmune liver diseases. Hepatology 2023; doi: 10.1097/HEP.0000000000000506
|
| 25 |
Taotao Zhou, Katja Bartelheimer, Fabian Ruping, Christian Rupp, Peter Sauer, Ronald Koschny, Arianeb Mehrabi, Markus Mieth, Rebecca von Haken, Karl Heinz Weiss, Daniel Nils Gotthardt, Conrad Rauber. Intrahepatic biliary strictures after liver transplantation are morphologically similar to primary sclerosing cholangitis but immunologically distinct. European Journal of Gastroenterology & Hepatology 2020; 32(2): 276 doi: 10.1097/MEG.0000000000001649
|
| 26 |
Beata Kasztelan-Szczerbinska, Anna Rycyk-Bojarzynska, Agnieszka Szczerbinska, Halina Cichoz-Lach. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview. Nutrients 2023; 15(3): 760 doi: 10.3390/nu15030760
|
| 27 |
Tamas Tornai, David Tornai, Nora Sipeki, Istvan Tornai, Rayan Alsulaimani, Kai Fechner, Dirk Roggenbuck, Gary L. Norman, Gabor Veres, Gabriella Par, Alajos Par, Ferenc Szalay, Peter Laszlo Lakatos, Peter Antal-Szalmas, Maria Papp. Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18622-1
|
| 28 |
Amandeep K. Dhillon, Martin Kummen, Marius Trøseid, Sissel Åkra, Evaggelia Liaskou, Bjørn Moum, Mette Vesterhus, Tom H. Karlsen, Ingebjørg Seljeflot, Johannes R. Hov, Gabriele Missale. Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis. Liver International 2019; 39(2): 371 doi: 10.1111/liv.13979
|
| 29 |
Kevin De Muynck, Lander Heyerick, Federico F. De Ponti, Bart Vanderborght, Tim Meese, Sanne Van Campenhout, Leen Baudonck, Eva Gijbels, Pedro M. Rodrigues, Jesus M. Banales, Mette Vesterhuus, Trine Folseraas, Charlotte L. Scott, Mathieu Vinken, Malaïka Van der Linden, Anne Hoorens, Jo Van Dorpe, Sander Lefere, Anja Geerts, Filip Van Nieuwerburgh, Xavier Verhelst, Hans Van Vlierberghe, Lindsey Devisscher. Osteopontin characterizes bile duct–associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis. Hepatology 2024; 79(2): 269 doi: 10.1097/HEP.0000000000000557
|
| 30 |
Liza Konnikova, Tanya O. Robinson, Anna H. Owings, James F. Shirley, Elisabeth Davis, Ying Tang, Sarah Wall, Jian Li, Mohammad H. Hasan, Raad Z. Gharaibeh, Lybil B. Mendoza Alvarez, Lisa K. Ryan, Andria Doty, Jack F. Chovanec, Michael P. O’Connell, Dianne E. Grunes, William P. Daley, Emeran Mayer, Lin Chang, Julia Liu, Scott B. Snapper, Joshua D. Milner, Sarah C. Glover, Jonathan J. Lyons. Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia. Journal of Allergy and Clinical Immunology 2021; 148(3): 813 doi: 10.1016/j.jaci.2021.04.004
|
| 31 |
Sufang Chen, Xiang Li, Yanling Wang, Panwei Mu, Chaojin Chen, Pinjie Huang, Dezhao Liu. Ginsenoside Rb1 attenuates intestinal ischemia/reperfusion‑induced inflammation and oxidative stress via activation of the PI3K/Akt/Nrf2 signaling pathway. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10018
|
| 32 |
Jing Zhang, Xue-Rong Lin, Yu-Ping Zhang, Li-Min Zhang, Hui-Bo Du, Li-Na Jiang, Zi-Gang Zhao, Chun-Yu Niu. Blockade of Stellate Ganglion Remediates Hemorrhagic Shock–Induced Intestinal Barrier Dysfunction. Journal of Surgical Research 2019; 244: 69 doi: 10.1016/j.jss.2019.06.007
|
| 33 |
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, Mark Deneau, Lisa Forman, Sumera I. Ilyas, Keri E. Lunsford, Mercedes Martinez, Gonzalo Sapisochin, Rachna Shroff, James H. Tabibian, David N. Assis. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023; 77(2): 659 doi: 10.1002/hep.32771
|
| 34 |
|
| 35 |
Sean W. Mateer, Andrea Mathe, Jessica Bruce, Gang Liu, Steven Maltby, Michael Fricker, Bridie J. Goggins, Hock L. Tay, Ellen Marks, Grace Burns, Richard Y. Kim, Kyra Minahan, Marjorie M. Walker, Robert C. Callister, Paul S. Foster, Jay C. Horvat, Philip M. Hansbro, Simon Keely. IL-6 Drives Neutrophil-Mediated Pulmonary Inflammation Associated with Bacteremia in Murine Models of Colitis. The American Journal of Pathology 2018; 188(7): 1625 doi: 10.1016/j.ajpath.2018.03.016
|
| 36 |
Marianela González-González, Camilo Díaz-Zepeda, Johana Eyzaguirre-Velásquez, Camila González-Arancibia, Javier A. Bravo, Marcela Julio-Pieper. Investigating Gut Permeability in Animal Models of Disease. Frontiers in Physiology 2019; 9 doi: 10.3389/fphys.2018.01962
|